Stanisic, S.; Cicchetti, A.; Porta, C.; Procopio, G.; Berto, P. Cost-Effectiveness of Cabozantinib in Second-Line Treatment of Metastatic Renal Cell Cancer (mRCC) in Italy. Grhta 2018, 5.